Leading the Next CBD Wave - Safety and Efficacy

Yasmin L. Hurd

doi:10.1001/jamapsychiatry.2019.4157

Leading the Next CBD Wave - Safety and Efficacy

Research output: Contribution to journal › Comment/debate

19 Scopus citations

Original language	English
Pages (from-to)	341-342
Number of pages	2
Journal	JAMA Psychiatry
Volume	77
Issue number	4
DOIs	https://doi.org/10.1001/jamapsychiatry.2019.4157
State	Published - Apr 2020

Access to Document

10.1001/jamapsychiatry.2019.4157

Cite this

@article{0ae7bf312b7846d595bda0d84f3e203d,

title = "Leading the Next CBD Wave - Safety and Efficacy",

author = "Hurd, {Yasmin L.}",

note = "Funding Information: Conflict of Interest Disclosures: Dr Hurd reports grants from the National Institute on Drug Abuse and CBD product and funds to the Icahn School of Medicine at Mount Sinai for a recently published article from GW Pharmaceuticals, which develops CBD products. ",

year = "2020",

month = apr,

doi = "10.1001/jamapsychiatry.2019.4157",

language = "English",

volume = "77",

pages = "341--342",

journal = "JAMA Psychiatry",

issn = "2168-622X",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - Leading the Next CBD Wave - Safety and Efficacy

AU - Hurd, Yasmin L.

N1 - Funding Information: Conflict of Interest Disclosures: Dr Hurd reports grants from the National Institute on Drug Abuse and CBD product and funds to the Icahn School of Medicine at Mount Sinai for a recently published article from GW Pharmaceuticals, which develops CBD products.

PY - 2020/4

Y1 - 2020/4

UR - http://www.scopus.com/inward/record.url?scp=85078270096&partnerID=8YFLogxK

U2 - 10.1001/jamapsychiatry.2019.4157

DO - 10.1001/jamapsychiatry.2019.4157

M3 - Comment/debate

C2 - 31940016

AN - SCOPUS:85078270096

SN - 2168-622X

VL - 77

SP - 341

EP - 342

JO - JAMA Psychiatry

JF - JAMA Psychiatry

IS - 4

ER -